Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06062342
Other study ID # 20230484
Secondary ID 1R01MH134269-01
Status Recruiting
Phase N/A
First received
Last updated
Start date February 2, 2024
Est. completion date June 30, 2029

Study information

Verified date February 2024
Source University of Miami
Contact Sannisha Dale, PhD
Phone (305) 243-6714
Email sdale@med.miami.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to assess the effectiveness of the FPI bundled implementation strategy in increasing HIV testing, Pre-exposure prophylaxis (PrEP) linkage (e.g., prescription) and knowledge, and condom use/access.


Recruitment information / eligibility

Status Recruiting
Enrollment 20400
Est. completion date June 30, 2029
Est. primary completion date December 1, 2028
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: • Any individual present during the community events at the "five points" (barbershop, hair/beauty salon store or salon, corner store/grocery/neighborhood restaurant, laundrymat in the predominantly Black communities in Miami where the prevalence of HIV is highest, car service provider (e.g. gas station, mechanic, car wash) in predominantly Black communities in Miami where HIV prevalence is high. Exclusion Criteria: • Individuals who are unable to completely and fully understand the informed (verbal) consent process and the study procedures.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
FPI
The FPI intervention will be conducted twice per month (across 21 months) in a zip code, and each event will last approximately 4-5 hours. At the event, participants will receive HIV testing, PrEP linkage (e.g., prescription) and knowledge, and condom and use/access.

Locations

Country Name City State
United States University of Miami Miami Florida

Sponsors (2)

Lead Sponsor Collaborator
University of Miami National Institute of Mental Health (NIMH)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in number of residents with recent HIV testing Will be reported as proportion of residents with recent (within 12 months) HIV testing as measured by Five Point Initiative - Community Survey Up to 23 months
Primary Change in number of residents with PrEP prescription Will be reported as proportion of residents with PrEP prescription as measured by Five Point Initiative - Community Survey Up to 23 months
Primary Change in PrEP knowledge as measured by Five Point Initiative - Community Survey Will be reported as the proportion of residents that indicated 'Yes' on the survey. Baseline and up to 23 months
Secondary Change in condom use as measured by Five Point Initiative - Community Survey Will be reported as the proportion of residents that indicated 'No' on the survey Baseline and up to 23 months
Secondary Change in condom access as measured by Five Point Initiative - Community Survey Will be reported as the proportion of residents that indicated 'Yes' on the survey Baseline and up to 23 months
Secondary Proportion of residents with recent HIV testing by health organizations Proportion of residents with recent (within 12 months) HIV testing by each of the participating health organizations. Up to 23 months
Secondary Number of residents with PrEP prescription by health organizations Number of residents with PrEP prescription by each of the participating health organizations. Up to 23 months
See also
  Status Clinical Trial Phase
Recruiting NCT06162897 - Case Management Dyad N/A
Completed NCT03999411 - Smartphone Intervention for Smoking Cessation and Improving Adherence to Treatment Among HIV Patients Phase 4
Completed NCT02528773 - Efficacy of ART to Interrupt HIV Transmission Networks
Recruiting NCT05454839 - Preferences for Services in a Patient's First Six Months on Antiretroviral Therapy for HIV in South Africa
Recruiting NCT05322629 - Stepped Care to Optimize PrEP Effectiveness in Pregnant and Postpartum Women N/A
Completed NCT02579135 - Reducing HIV Risk Among Adolescents: Evaluating Project HEART N/A
Active, not recruiting NCT01790373 - Evaluating a Youth-Focused Economic Empowerment Approach to HIV Treatment Adherence N/A
Not yet recruiting NCT06044792 - The Influence of Primary HIV-1 Drug Resistance Mutations on Immune Reconstruction in PLWH
Completed NCT04039217 - Antiretroviral Therapy (ART) Persistence in Different Body Compartments in HIV Negative MSM Phase 4
Active, not recruiting NCT04519970 - Clinical Opportunities and Management to Exploit Biktarvy as Asynchronous Connection Key (COMEBACK) N/A
Completed NCT04124536 - Combination Partner HIV Testing Strategies for HIV-positive and HIV-negative Pregnant Women N/A
Recruiting NCT05599581 - Tu'Washindi RCT: Adolescent Girls in Kenya Taking Control of Their Health N/A
Active, not recruiting NCT04588883 - Strengthening Families Living With HIV in Kenya N/A
Completed NCT02758093 - Speed of Processing Training in Adults With HIV N/A
Completed NCT02500446 - Dolutegravir Impact on Residual Replication Phase 4
Completed NCT03805451 - Life Steps for PrEP for Youth N/A
Active, not recruiting NCT03902431 - Translating the ABCS Into HIV Care N/A
Completed NCT00729391 - Women-Focused HIV Prevention in the Western Cape Phase 2/Phase 3
Recruiting NCT05736588 - Elimisha HPV (Human Papillomavirus) N/A
Recruiting NCT03589040 - Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant Phase 2